Latest Sotac Pharmaceuticals stock price
Sotac Pharmaceuticals P/E Ratio
SOTAC • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
13.23
Low Valuation
Low - May indicate good value opportunity
Current Valuation Metrics
P/E Ratio
13.23
Current Price
₹
EPS (TTM)
₹7.26
Exchange
None
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
49.59
Sector Median
26.63
Sector Rank
#11 of 139
Sector Percentile
7.9%
Earnings Breakdown (TTM)
TTM EPS
₹3.81
Sept 2024
₹0.42
Mar 2024
₹1.49
Key P/E Ratio Insights for Sotac Pharmaceuticals
- Stock appears undervalued with PE of 13.23, suggesting potential buying opportunity
- Trading at discount to sector average PE of 49.59
View the SOTAC equity price for detailed stock performance.
Related Pages for Sotac Pharmaceuticals
Additional stock information and data for SOTAC
Sector P/E Ratio Comparison
Comparing Sotac Pharmaceuticals with other companies in Healthcare sector
Sector Average
49.59
Sector Median
26.63
Lowest P/E
0.97
Highest P/E
993.26
Companies
139
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 3.0 | ₹43 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.67 | ₹1,166 | Low |
| Medicamen Organics | MEDIORG | 6.33 | ₹26 | Low |
| Amwill Health Care | AMWILL | 6.53 | ₹70 | Low |
| Galaxy Medicare | GML | 7.25 | ₹24 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.74 | ₹2,188 | Low |
| Zenith Drugs | ZENITHDRUG | 7.9 | ₹76 | Low |
| Brooks Laboratories | BROOKS | 8.01 | ₹184 | Low |
| Vasundhara Rasayans | VRL | 9.97 | ₹37 | Low |